Drug Product
Clinical Trial Supply & Logistics
Regulatory, Tech Transfer & Support Services
Company Overview
About
Birgi Mefar Group (BMG) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Neurology
Quick Facts
HQ:Turkey
Founded:2007
Employees:1,479
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval XXGF7S
Health Canada · #APR-ZB5D8V73 · 2018-12-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-E0S8ARH0
Issued: 2020-10-01
Expires: 2025-02-26
Health Canada GMP
Health Canada
Cert #: CERT-SNB513TB
Issued: 2020-07-16
Expires: 2025-11-15
Loading CDMO intelligence...
Key facts about Birgi Mefar Group (BMG)
- Birgi Mefar Group (BMG) is headquartered in Turkey.
- Birgi Mefar Group (BMG) was founded in 2007.
- Birgi Mefar Group (BMG) has 1,479 employees.
- Birgi Mefar Group (BMG)'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Birgi Mefar Group (BMG)
Directory pages this company appears in, each with the full list of matching manufacturers.